
SRTAW — Strata Critical Medical, Inc.
NASDAQ
$0.00
-$0.00 (-88.68%)
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ. It is led by Melissa M. Tomkiel J.D., based in 31 Hudson Yards, New York, NY, United States, 10001, with about 327 employees. Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
Latest reported SRTAW revenue for 2025-09-30 was $49.3M. Net income was $57.4M. Revenue was down 30.4% from 2025-06-30 to 2025-09-30.
Use this SRTAW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SRTAW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SRTAW SEC filings page. Lician reads the product cache first so this HTML stays unique to Strata Critical Medical, Inc. even when a live quote feed is slow.
About Strata Critical Medical, Inc.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.
SRTAW Key Statistics
Market Cap
$0.00M
Volume
638,916
Previous Close
$0.01
Day Range
$0.00 – $0.00
EPS
-$0.35
Revenue
$248.69M
Net Income
-$27.31M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+10.4%
Profit Margin
-11.0%
Employees
327
SRTAW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $248.69M | $225.18M | $146.12M | $24.62M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$27.31M | -$56.08M | -$27.26M | $772.00K |
| EPS (Diluted) | -$0.35 | -$0.76 | -$0.38 | $0.01 |
Total Assets
$256.68M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$18.38M
Operating Cash Flow
-$2.52M
Free Cash Flow
$0.00
Strata Critical Medical, Inc. Company Information
- Co- CEO, General Counsel, Corporate Secretary & Director
- Melissa M. Tomkiel J.D.
- Headquarters
- 31 Hudson Yards, New York, NY, United States, 10001
- Website
- www.stratacritical.com
- Phone
- 585 301 1762
- IPO / Founded
- 2025-08-29